The fasting-refeeding regimen increased Akt phosphorylation. حسب Tucker Hopkins (20790529)

RT-qPCR Primer. حسب Dequan Wang (6007007)

الموضوعات:

CCND1 is a target gene of miR-1247-3p. حسب Dequan Wang (6007007)

الموضوعات:

miR-1247-3p was downregulated in CRC resistant cells. حسب Dequan Wang (6007007)

الموضوعات:

miR-1247-3p plasmid. حسب Dequan Wang (6007007)

الموضوعات:

RNA-sequencing data screening for miR-1247-3p target genes. حسب Dequan Wang (6007007)

الموضوعات:

Dual luciferase primer. حسب Dequan Wang (6007007)

الموضوعات:

shCCND1 plasmid. حسب Dequan Wang (6007007)

الموضوعات:

CCND1 promoted chemoresistance in CRC. حسب Dequan Wang (6007007)

الموضوعات:

Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. حسب Dequan Wang (6007007)

الموضوعات:

Effect of miR-1247-3p on survival in colorectal cancer patients. حسب Dequan Wang (6007007)

الموضوعات:

S1 Raw images - حسب Dequan Wang (6007007)

الموضوعات:

Introduction to the dataset. حسب Dequan Wang (6007007)

الموضوعات:

Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. حسب Dequan Wang (6007007)

الموضوعات:

miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance. حسب Dequan Wang (6007007)

الموضوعات:

<b>The loss of insulin-positive cell clusters precedes the decrease of islet frequency and beta cell area in type 1 diabetes</b> حسب Denise M. Drotar (21679539)

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. حسب Michele Angelo Colombo (22446342)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"